EditorialPreventing preeclampsia with aspirin: does dose or timing matter?
References (19)
- et al.
Aspirin for the treatment of recurrent toxemia
Lancet
(1978) - et al.
The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP
Pregnancy Hypertens
(2014) - et al.
SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary
J Obstet Gynaecol Can
(2014) - et al.
PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Lancet
(2007) - et al.
Pathophysiology of preeclampsia: links with implantation disorders
Eur J Obstet Gynecol Reprod Biol
(2004) - et al.
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction
Am J Obstet Gynecol
(2016) - et al.
Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial
Am J Obstet Gynecol
(2016) - et al.
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis
Obstet Gynecol
(2010) - et al.
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
Ultrasound Obstet Gynecol
(2013)
Cited by (31)
Preventing maternal morbidity and mortality from preeclampsia and eclampsia particularly in low- and middle-income countries
2024, Best Practice and Research: Clinical Obstetrics and GynaecologyPreeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation
2022, American Journal of Obstetrics and GynecologyCitation Excerpt :Studies have reported associations of adverse neurodevelopmental and cardiovascular outcomes in offspring in association with in utero exposure to preeclampsia.15–17 Low-dose prenatal aspirin use has been found in many studies to decrease the risk of preeclampsia18,19; however, optimal strategy for implementation (eg, eligible pregnancies, dosing, or gestational age at initiation and discontinuation) is still an area of ongoing debate and study.20–26 Remote home blood pressure (BP) monitoring, which has increased in popularity during the COVID-19 pandemic, is feasible for the identification of subpopulations with BP elevations who benefit from greater monitoring and treatment, particularly those at higher risk of morbidity and mortality, such as Black birthing people.27–29
Pre-eclampsia
2021, The LancetDoes low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?
2020, American Journal of Obstetrics and GynecologyProspective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
2019, American Journal of Obstetrics and Gynecology
Dr Mol is a consultant for ObsEva, Geneva.